Windsor Financial Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$691K Buy
9,769
+772
+9% +$51.4K 0.32% 47
2017
Q1
$611K Sell
8,997
-2,075
-19% -$146K 0.28% 50
2016
Q4
$793K Sell
11,072
-2,400
-18% -$178K 0.38% 49
2016
Q3
$1.07M Sell
13,472
-29,763
-69% -$2.42M 0.5% 47
2016
Q2
$3.61M Buy
43,235
+5,010
+13% +$445K 1.65% 33
2016
Q1
$3.51M Buy
38,225
+3,647
+11% +$329K 1.61% 34
2015
Q4
$3.5M Buy
+34,578
New +$3.6M 1.7% 33

Other funds holding GILD

Windsor Financial Group's GILD Position: Q2 2017 in Review

Windsor Financial Group increased its Gilead Sciences (GILD) stake by 8.6% in Q2 2017, buying an estimated $51.4K and bringing the position to 9,769 shares worth $691K. The position accounts for 0.32% of the portfolio, ranked #47.

Windsor Financial Group first reported a position in GILD in Q4 2015 and has held it in 7 quarters since. The position peaked at $3.61M in Q2 2016. 1,519 funds tracked by Wall St. Rank hold GILD as of Q2 2017.

  • Windsor Financial Group held 9,769 shares of Gilead Sciences worth $691K as of Q2 2017.
  • Windsor Financial Group bought 772 Gilead Sciences shares in Q2 2017, an estimated $51.4K.
  • Gilead Sciences made up 0.32% of Windsor Financial Group's portfolio in Q2 2017, its #47 holding.
  • Windsor Financial Group first reported a position in Gilead Sciences in Q4 2015 and has held it in 7 quarters since.
  • Windsor Financial Group's Gilead Sciences position peaked at $3.61M in Q2 2016.
  • 1,519 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.

Based on Windsor Financial Group's 13F filing for Q2 2017, filed 3 Aug 2017.